...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara

Why go to all the trouble and expense of early 2020 conferences if Zenith Epigenetics is being sold or partnered ,  If there are no conferences booked for the next 6 months, trying to  read the tea leaves , i think there is a good chance Zenith will be sold off, At this point , I think DM and team know that have to pass the ball on to a major BP to take this to the next level,  They can't do it on their own,

Has anyone seen any listed conferences for Zenith for the upcoming year?Where there is smoke there is fire??

Share
New Message
Please login to post a reply